Follow
Trilok Shrivastava
Trilok Shrivastava
Resident Physician, John H Stroger Hospital of Cook County
Verified email at cookcountyhhs.org
Title
Cited by
Cited by
Year
Rare cause of large anterior mediastinal mass––Thymolipoma
T Shrivastava, P Ntiamoah
Radiology Case Reports 15 (9), 1538-1540, 2020
52020
Targeting B cell maturation antigen in patients with multiple myeloma: current perspectives
T Shrivastava, F Van Rhee, S Al Hadidi
OncoTargets and Therapy, 441-464, 2023
42023
Does High-Dose Thromboprophylaxis Improve Outcomes in COVID-19 Patients? A Meta-analysis of Comparative Studies
MAT Elsebaie, B Baral, M Elsebaie, T Shrivastava, C Weir, D Kumi, ...
TH Open 6 (04), e323-e334, 2022
12022
Racial disparity in survival of African-American (AA) patients diagnosed with metastatic prostate cancer: Analysis of surveillance epidemiology and end results program.
MZ Farooq, T Shrivastava, H Sarfraz, SH Ba Aqeel, P Fu, A Mangla
Journal of Clinical Oncology 40 (6_suppl), 28-28, 2022
12022
Survival outcomes of primary mediastinal germ cell malignancies based on clinicopathological characteristics: A SEER database analysis.
T Shrivastava, B Baral, G Pudasaini, P Lingamaneni, K Batra, ...
Journal of Clinical Oncology 39 (15_suppl), e17055-e17055, 2021
12021
A case report of mesenchymal scapular FGF secreting tumor: Importance of follow up in tumor induced osteomalacia
T Shrivastava, JL Hwang, L Munshi, KK Batra, K Ahuja
Radiology Case Reports 16 (4), 989-993, 2021
12021
Clinical outcomes of prophylactic vs. Therapeutic doses of anticoagulation in COVID-19 Patients: A systematic reviewand meta-analysis
MA Elsebaie, B Baral, T Shrivastava, MJ Tariq, D Kumi, M Elsebaie
Research and Practice in Thrombosis and Haemostasis, 2021
12021
Clostridium difficile infection is independently associated with significantly worse outcomes in acute leukemia patients undergoing chemotherapy and/or hematopoietic stem cell …
P Lingamaneni, V Katiyar, K Moturi, B Baral, I Vohra, T Shrivastava, M Zia
Blood 136, 13-14, 2020
12020
A Single Center Experience of T Cell Redirecting Therapy Post Stem Cell Transplantation in Relapsed Multiple Myeloma
A Trikannad, S Vellanki, R Bachu, T Patel, T Shrivastava, S Iska, ...
Transplantation and Cellular Therapy 30 (2), S221, 2024
2024
Psychological Impact in Individuals with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
TH Patel, R Bachu, T Shrivastava, J Alrawabdeh, M Alzubi, J Hastings, ...
Blood 142, 6764, 2023
2023
Sixth Nerve Palsy From Multiple Myeloma in Central Nervous System: Case Series and Review of Current Literature
N Thalambedu, P Damalcheruvu, Y Ogunsesan, T Patel, R Bachu, ...
Cureus 15 (6), 2023
2023
TH Open
MA Elsebaie, B Baral, M Elsebaie, T Shrivastava, C Weir, D Kumi, N Birch
2022
Long-term time trends in incidence, survival, and mortality of malignant melanoma in the United States.
T Shrivastava, P Ghimire, P Lingamaneni, K Ahuja, K Batra
Journal of Clinical Oncology 40 (16_suppl), e21599-e21599, 2022
2022
Development of breast cancer after thyroid cancer and trends over time.
K Ahuja, T Shrivastava, M Shah, M Dasgupta, E Abate, ...
Journal of Clinical Oncology 40 (16_suppl), 12066-12066, 2022
2022
In-hospital outcomes of transcatheter aortic valve replacement (TAVR) in patients with localized and metastatic malignancy.
H Macchi, M Salazar, J Del Cid Fratti, E Gauto, B Baral, T Shrivastava, ...
Journal of Clinical Oncology 39 (15_suppl), e18602-e18602, 2021
2021
Predictors of 30-day readmission rate after liver transplant in patients with hepatocellular carcinoma.
M Salazar, SU Upadhyay Banskota, LA Acevedo, P Palacios, E Gauto, ...
Journal of Clinical Oncology 39 (15_suppl), e16193-e16193, 2021
2021
Thirty day readmissions and outcomes following radical nephrectomy in renal cell carcinoma: A nationwide analysis.
T Shrivastava, M Salazar, V Prado, E Gauto, B Baral, S Upadhyay, ...
Journal of Clinical Oncology 39 (15_suppl), e16560-e16560, 2021
2021
Impact and predictors of readmission in hypercalcemia of malignancy: Findings of a nationwide analysis.
B Baral, M Salazar, V Prado, E Gauto, S Upadhyay, T Shrivastava, ...
Journal of Clinical Oncology 39 (15_suppl), e18809-e18809, 2021
2021
Predictors of 30-day readmission rate after total gastrectomy in patients with gastric malignancy.
M Salazar, E Gauto, SU Upadhyay Banskota, P Palacios, T Shrivastava, ...
Journal of Clinical Oncology 39 (15_suppl), e16109-e16109, 2021
2021
Health care utilization and outcomes of sepsis in HIV versus non-HIV patients with Burkitt Lymphoma: A nationwide analysis.
B Baral, MJ Tariq, P Lingamaneni, A Baranwal, T Shrivastava, MU Almani, ...
Journal of Clinical Oncology 39 (15_suppl), e19561-e19561, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–20